ESAB Esab (ESAB) Insider Trading, Ownership & Congress Trades
Industrials · General industrial machinery & equipment, nec · CIK 0001877322
Congress · 1Form 144 · 1
Insider buyers, 180 days
0
Funds added, last quarter
188
13F, latest reported quarter
Conversions, 180 days
8
Codes C/M, not in net · $33.3K priced
What the filings say about ESAB
Insiders, 180 days
-$95.0K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 0 sold
Latest: purchase, 2026-07-07
Planned sales (Form 144), 90 days
$95.0K
1 notice
Esab insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ESAB Corp insiders sold a net $95.0K of stock across 70 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 13, 2025.
- No other insider sold within 30 days.
- 188 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Jordan Rhonda L sold about $95.0K of ESAB on Aug 7, 2026; 188 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 7, 2023.
- The trade is 19.7% of the 11,193 shares held after it.
- 2 other insiders sold within 30 days.
- 188 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer Campion Michele sold about $269.8K of ESAB on Feb 27, 2026; 2 other insiders sold within 30 days and 188 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 7, 2023.
- The trade is 25.9% of the 11,193 shares held after it.
- 2 other insiders sold within 30 days.
- 188 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer Campion Michele sold about $355.1K of ESAB on Feb 27, 2026; 2 other insiders sold within 30 days and 188 funds added in the latest 13F quarter.Context
- 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Oct 29, 2024.
- The trade is 11.1% of the 114,277 shares held after it.
- 2 other insiders sold within 30 days.
- 188 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Kambeyanda Shyam sold about $1.6M of ESAB on Feb 23, 2026, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 188 funds added in the latest 13F quarter.Context
- 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Oct 29, 2024.
- The trade is 1.7% of the 99,864 shares held after it.
- 2 other insiders sold within 30 days.
- 188 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Kambeyanda Shyam sold about $218.9K of ESAB on Feb 23, 2026; 2 other insiders sold within 30 days and 188 funds added in the latest 13F quarter.70 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$95.0K over 180 days
-$95.0K over 90 days
more than 76% of Industrials
Congress
1 member bought in the last year
the lowest in Industrials
Funds
188 funds bought in last quarter
more than 57% of Industrials
Revenue
+3.7% year over year
below 56% of Industrials
Margin
8.0% net margin
more than 64% of Industrials
Buybacks
no share repurchases reported
Short interest
8.9% of the float short (float per yahoo 2026-10-26) · 4.8 days to cover · settled 2026-09-30
more than 89% of Industrials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ESAB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-45.3%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ESAB: institutional holders (13F)
13F holdings, latest reported quarter
5,318,185 sh
$524.5M
2,770,472 sh
$273.3M
2,609,497 sh
$257.4M
2,475,282 sh
$244.1M
2,341,633 sh
$231.0M
Congress trades in ESAB
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-07-07 · disclosed 42 days later
$1,001 - $15,000
Bought 2026-06-24 · disclosed 21 days later
$1,001 - $15,000
Bought 2026-06-22 · disclosed 23 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ESAB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Jordan Rhonda L
Filed 2026-08-07
$95.0K
ESAB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
DAVENPORT SMALL CAP FOCUS FUND
$23.1M position · as of 2026-06-30
3.7%
FAM SMALL CAP FUND
$10.1M position · as of 2026-06-30
3.3%
DAVENPORT EQUITY OPPORTUNITIES FUND
$25.4M position · as of 2026-06-30
3.2%
Hunter Small Cap Value Fund
$1.8M position · as of 2026-07-31
2.7%
Small-Company Stock Fund
$4.9M position · as of 2026-06-30
2.3%
DIAMOND HILL SMALL CAP FUND
$6.7M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Shyam P. Kambeyanda
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.7M
$5.0M
$2.7M
+152%
+66%
2024
$8.0M
$19.5M
$2.2M
+170%
+47%
2023
$7.9M
$18.0M
$2.4M
+94%
+29%
2022
$9.5M
$9.4M
$2.6M
+5%
-2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $95.0K sold by insiders over 180 days, 188 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $95.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ESAB financials
Revenue growth
+3.7%
XBRL, annual
Net margin
8.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.0B
four quarters, 2025-07-05 to 2026-07-03
Revenue, TTM ESAB
| FY Dec 2025 | $2.8B |
| FY Dec 2024 | $2.7B |
| FY Dec 2023 | $2.8B |
| FY Dec 2022 | $2.6B |
| FY Dec 2021 | $2.4B |
| Jul 2026 | $807.6M |
| Apr 2026 | $745.6M |
| Dec 2025 | $721.0M |
| Oct 2025 | $727.8M |
| Jul 2025 | $715.6M |
| Apr 2025 | $678.1M |
| Dec 2024 | $670.8M |
| Sep 2024 | $673.2M |
At each fiscal year end
Single quarter
Net margin, TTM
+5.7%
net income over revenue, 2025-07-05 to 2026-07-03
Net margin, TTM ESAB
| FY Dec 2025 | +8.0% |
| FY Dec 2024 | +9.7% |
| FY Dec 2023 | +7.4% |
| FY Dec 2022 | +8.6% |
| FY Dec 2021 | +9.7% |
| Jul 2026 | +4.0% |
| Apr 2026 | +6.4% |
| Dec 2025 | +5.2% |
| Oct 2025 | +7.5% |
| Jul 2025 | +9.3% |
| Apr 2025 | +9.9% |
| Dec 2024 | +8.0% |
| Sep 2024 | +10.1% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$196.6M
operating cash flow minus capex, 2025-07-05 to 2026-07-03
Free cash flow, TTM ESAB
| FY Dec 2025 | $213.3M |
| FY Dec 2024 | $303.6M |
| FY Dec 2023 | $282.3M |
| FY Dec 2022 | $174.1M |
| FY Dec 2021 | $215.2M |
| Jul 2026 | $15.7M |
| Apr 2026 | $33.2M |
| Dec 2025 | $77.4M |
| Oct 2025 | $70.3M |
| Jul 2025 | $37.4M |
| Apr 2025 | $28.1M |
| Dec 2024 | $102.2M |
| Sep 2024 | $90.4M |
At each fiscal year end
Single quarter
Debt to equity
0.94x
long-term 2026-07-03 plus current 2026-07-03; equity 2026-07-03
Debt to equity ESAB
| FY Dec 2025 | 0.57x |
| FY Dec 2024 | 0.61x |
| FY Dec 2023 | 0.63x |
| FY Dec 2022 | 0.90x |
| FY Dec 2021 | 0.00x |
| Jul 2026 | 0.94x |
| Apr 2026 | 0.93x |
| Dec 2025 | 0.57x |
| Oct 2025 | 0.63x |
| Jul 2025 | 0.52x |
| Apr 2025 | 0.56x |
| Dec 2024 | 0.61x |
| Sep 2024 | 0.59x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.11x
TTM operating cash flow over long-term 2026-07-03 plus current 2026-07-03
Cash flow to debt ESAB
| FY Dec 2025 | 0.21x |
| FY Dec 2024 | 0.33x |
| FY Dec 2023 | 0.32x |
| FY Dec 2022 | 0.18x |
| FY Dec 2021 | n/a |
| Jul 2026 | 0.11x |
| Apr 2026 | 0.13x |
| Dec 2025 | 0.21x |
| Oct 2025 | 0.22x |
| Jul 2025 | 0.29x |
| Apr 2025 | 0.32x |
| Dec 2024 | 0.33x |
| Sep 2024 | 0.32x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.5%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on equity ESAB
| FY Dec 2025 | +11.5% |
| FY Dec 2024 | +15.7% |
| FY Dec 2023 | +13.9% |
| FY Dec 2022 | +11.7% |
| FY Dec 2021 | +9.4% |
| Jul 2026 | +7.5% |
| Apr 2026 | +10.1% |
| Dec 2025 | +11.5% |
| Oct 2025 | +12.3% |
| Jul 2025 | +13.6% |
| Apr 2025 | +15.3% |
| Dec 2024 | +15.7% |
| Sep 2024 | +15.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.1%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on assets ESAB
| FY Dec 2025 | +5.2% |
| FY Dec 2024 | +6.7% |
| FY Dec 2023 | +5.4% |
| FY Dec 2022 | +6.2% |
| FY Dec 2021 | +6.8% |
| Jul 2026 | +3.1% |
| Apr 2026 | +4.2% |
| Dec 2025 | +5.2% |
| Oct 2025 | +5.4% |
| Jul 2025 | +6.1% |
| Apr 2025 | +6.8% |
| Dec 2024 | +6.7% |
| Sep 2024 | +6.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+6.4%
operating income after a 21.2% effective tax rate, over long-term 2026-07-03 plus current 2026-07-03 plus average of 2025-07-04 and 2026-07-03 minus cash
Return on invested capital ESAB
| FY Dec 2025 | +10.9% |
| FY Dec 2024 | +13.7% |
| FY Dec 2023 | +11.7% |
| FY Dec 2022 | +8.3% |
| FY Dec 2021 | +9.3% |
| Jul 2026 | +6.4% |
| Apr 2026 | +9.1% |
| Dec 2025 | +10.9% |
| Oct 2025 | +11.1% |
| Jul 2025 | +12.5% |
| Apr 2025 | +13.3% |
| Dec 2024 | +13.7% |
| Sep 2024 | +13.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.6%
operating income (EBIT proxy) over average of 2025-07-04 and 2026-07-03 minus current liabilities
Return on capital employed ESAB
| FY Dec 2025 | +11.0% |
| FY Dec 2024 | +13.5% |
| FY Dec 2023 | +12.7% |
| FY Dec 2022 | +10.9% |
| FY Dec 2021 | +10.7% |
| Jul 2026 | +7.6% |
| Apr 2026 | +9.3% |
| Dec 2025 | +11.0% |
| Oct 2025 | +11.4% |
| Jul 2025 | +12.4% |
| Apr 2025 | +13.3% |
| Dec 2024 | +13.5% |
| Sep 2024 | +13.3% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
24.21x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-05 to 2026-07-03
P/E, trailing ESAB
| FY Dec 2025 | 30.28x |
| FY Dec 2024 | 27.83x |
| FY Dec 2023 | 25.86x |
| FY Dec 2022 | 12.68x |
| FY Dec 2021 | n/a |
| Jul 2026 | 33.37x |
| Apr 2026 | 29.19x |
| Dec 2025 | 30.28x |
| Oct 2025 | 29.69x |
| Jul 2025 | 30.08x |
| Apr 2025 | 24.18x |
| Dec 2024 | 27.83x |
| Sep 2024 | 25.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$6.4B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term 2026-07-03 plus current 2026-07-03, minus cash 2026-07-03
Enterprise value ESAB
| FY Dec 2025 | $7.8B |
| FY Dec 2024 | $8.1B |
| FY Dec 2023 | $6.1B |
| FY Dec 2022 | $4.0B |
| FY Dec 2021 | n/a |
| Jul 2026 | $7.8B |
| Apr 2026 | $7.0B |
| Dec 2025 | $7.8B |
| Oct 2025 | $8.3B |
| Jul 2025 | $8.4B |
| Apr 2025 | $7.3B |
| Dec 2024 | $8.1B |
| Sep 2024 | $7.3B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield ESAB
| FY Dec 2025 | +3.1% |
| FY Dec 2024 | +4.2% |
| FY Dec 2023 | +5.4% |
| FY Dec 2022 | +6.2% |
| FY Dec 2021 | n/a |
| Jul 2026 | +3.5% |
| Apr 2026 | +3.7% |
| Dec 2025 | +3.1% |
| Oct 2025 | +3.3% |
| Jul 2025 | +3.4% |
| Apr 2025 | +4.5% |
| Dec 2024 | +4.2% |
| Sep 2024 | +4.7% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -33%, PEG needs growth
PEG, trailing ESAB
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.97x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Dec 2025 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | 15.38x |
| Apr 2025 | 1.49x |
| Dec 2024 | 0.97x |
| Sep 2024 | 1.21x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.8B | $2.6B |
| Gross profit | $1.0B | $1.0B | $1.0B | $885.5M |
| Operating income | $412.2M | $447.4M | $404.2M | $329.1M |
| Net income | $226.8M | $264.8M | $205.3M | $223.7M |
| EPS (diluted) | 3.67 | 4.31 | 3.36 | 3.69 |
| Operating cash flow | $260.6M | $355.4M | $330.5M | $214.4M |
| Cash | $185.9M | $249.4M | $102.0M | $72.0M |
| Long-term debt | $1.2B | $1.1B | $1.0B | $1.2B |
| Dividends paid | $21.9M | $17.0M | $13.3M | $6.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
ESAB Stock Sonar score 6/7 axes
Find similar shapesCompareESAB ranks highest on institutional and government (70th percentile) and risk and compliance (56th), and lowest on financial health (22nd), among Industrials peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ESAB filings, in plain words
Are Esab insiders buying or selling ESAB?
In the 180 days to 2026-10-28, Esab insiders were net sellers, a net $95.0K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded ESAB?
Yes. In the year to 2026-10-28, 1 House member disclosed buying ESAB and 0 House members disclosed selling it; the latest on record is a purchase by Thomas H. Kean dated 2026-07-07.
Are there planned insider sales of ESAB?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $95.0K of stock; the latest, by Jordan Rhonda L, was filed 2026-08-07.
Read the full summary
In the 180 days to 2026-10-28, Esab insiders were net sellers of ESAB, a net $95.0K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-28, 1 member of Congress disclosed buying ESAB and 0 members disclosed selling it; the latest on record is a purchase by Thomas H. Kean dated 2026-07-07. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $95.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
